Roivant director disposes 2,179 shares for tax

Roivant Sciences director Melissa B. Epperly had shares withheld to cover tax obligations on vested equity awards, leaving her with 14,838 common shares.

Rhea-AI Filing Summary

Roivant Sciences Ltd. (ROIV) reported that director Melissa B. Epperly had 2,179 Common Shares withheld on September 10, 2026, as a tax-withholding disposition connected to the vesting and settlement of previously granted shares under the Non-Employee Director Compensation Plan. After this net-share settlement for tax liabilities, she directly holds 14,838 Common Shares.

Insider Trade Summary

Tax Withholding: 2,179 shares

Tax Withholding 1 txn

Insider Epperly Melissa B,

Role Director

Type	Security	Shares	Price	Value
Tax Withholding	Common Shares F1	2,179	$40.94	$89K

Holdings After Transaction: Common Shares — 14,838 shares (Direct)

Footnotes (1)

1. F1. Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.

Key Figures

Shares withheld for taxes: 2,179 shares Price per share: $40.94 per share Shares held after transaction: 14,838 shares

3 metrics

Shares withheld for taxes 2,179 shares Common Shares delivered or withheld on September 10, 2026 for tax liability

Price per share $40.94 per share Value used for the 2,179-share tax-withholding disposition

Shares held after transaction 14,838 shares Direct Common Share ownership by Melissa B. Epperly after the Form 4 transaction

Key Terms

net settlement, Non-Employee Director Compensation Plan, tax withholding obligations

3 terms

net settlement financial

"Represents the "net settlement" by the Issuer of Common Shares"

Non-Employee Director Compensation Plan financial

"granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan"

tax withholding obligations financial

"in order to satisfy applicable tax withholding obligations in connection with the vesting"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did ROIV director Melissa B. Epperly report?

She reported a tax-withholding disposition of 2,179 Common Shares on September 10, 2026, where shares were withheld in a net settlement to satisfy tax obligations arising from vesting and settlement of previously granted shares.

How many Roivant Sciences (ROIV) shares does Melissa B. Epperly hold after this Form 4?

After the reported transaction, Melissa B. Epperly directly holds 14,838 Common Shares of Roivant Sciences Ltd., as disclosed in the filing.

Was the ROIV Form 4 transaction by Melissa B. Epperly an open-market sale?

No. The filing describes the transaction as a payment of tax liability by delivering or withholding securities, i.e., a net-share settlement for tax withholding, not an open-market sale.

What price per share is associated with Melissa B. Epperly’s tax-withholding transaction in ROIV?

The tax-withholding disposition is reported at $40.94 per Common Share for the 2,179 shares used to satisfy tax obligations tied to vested equity.

Were Melissa B. Epperly’s ROIV transactions made under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as being pursuant to such a plan, and no footnote states that this transaction was executed under a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/14/2026 - 06:34 PM Accepted by SEC EDGAR 09/14/2026 - 06:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Epperly Melissa B,

(Last) (First) (Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON SW1H 0DB

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Shares	09/10/2026		F		2,179(1)	D	$40.94	14,838	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the "net settlement" by the Issuer of Common Shares previously granted to the reporting person pursuant to the Issuer's Non-Employee Director Compensation Plan in order to satisfy applicable tax withholding obligations in connection with the vesting and settlement of such Common Shares.

Remarks:

	By: /s/ Sam Kaplan, as Attorney-in-Fact for Melissa Epperly	09/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)